Trial result ·
Real-Time Electronic Patient-Reported Outcome Monitoring With Digital Triage and Care-Team Integration in Early Breast Cancer: ENABLE Randomized Controlled Trial.
Written based on 1 research study on PubMed, searched on 3 Nov 2026.
What was studied
This trial tested a digital check-in tool in early breast cancer. It was used during drug treatment. Weekly screening, rule-based triage and care team alerts were added to an app. A control group had the same app but no alerts. In all, 605 people were randomized at 2 German hospitals. The main aim was quality of life.
What they found
The analysis covered 487 people. At the end, the tool group had less fatigue, with a gap of -3.90. Social participation was higher, with a gap of +2.84. Anxiety was lower, with a gap of -2.10. Other measures showed no clear gap after adjustment. All gaps were below the 5-point minimal important difference. Of 209 monitored people, 160 triggered at least 1 alert. No harms from the tool were found.
What it means for patients
The authors say benefits were limited to some areas and below the important-difference level. They see the tool as a support workflow. It works where a team acts on alerts. They say it is not a stand-alone fix for treatment-related problems.
Why it is not certain yet
The trial was open-label. The control group had an app too, not usual care. After adjustment, many measures showed no clear gap. The abstract does not give results beyond the end of treatment.
Source
Real-Time Electronic Patient-Reported Outcome Monitoring With Digital Triage and Care-Team Integration in Early Breast Cancer: ENABLE Randomized Controlled Trial.
PubMed · PMID 42954133We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Metastatic breast cancer publications